Credit Suisse’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $18M | Hold |
1,200,000
| – | – | 0.02% | 660 |
|
|
2023
Q4 | $18M | Buy |
1,200,000
+140,000
| +13% | +$2.1M | 0.02% | 689 |
|
|
2023
Q3 | $14.9M | Hold |
1,060,000
| – | – | 0.02% | 731 |
|
|
2023
Q2 | $11M | Hold |
1,060,000
| – | – | 0.01% | 870 |
|
|
2023
Q1 | $9.79M | Hold |
1,060,000
| – | – | 0.01% | 936 |
|
|
2022
Q4 | $9.4M | Hold |
1,060,000
| – | – | 0.01% | 954 |
|
|
2022
Q3 | $8.82M | Sell |
1,060,000
-10
| -0% | -$83 | 0.01% | 966 |
|
|
2022
Q2 | $8.68M | Sell |
1,060,010
-25,511
| -2% | -$209K | 0.01% | 981 |
|
|
2022
Q1 | $9.46M | Sell |
1,085,521
-228
| -0% | -$1.99K | 0.01% | 1063 |
|
|
2021
Q4 | $10.3M | Buy |
1,085,749
+78
| +0% | +$742 | 0.01% | 1090 |
|
|
2021
Q3 | $18.3M | Sell |
1,085,671
-197
| -0% | -$3.31K | 0.01% | 836 |
|
|
2021
Q2 | $16.6M | Sell |
1,085,868
-34,843
| -3% | -$532K | 0.01% | 914 |
|
|
2021
Q1 | $21.8M | Sell |
1,120,711
-360
| -0% | -$7.01K | 0.01% | 821 |
|
|
2020
Q4 | $20.2M | Buy |
1,121,071
+6,788
| +0.6% | +$122K | 0.01% | 828 |
|
|
2020
Q3 | $21.5M | Buy |
1,114,283
+201,105
| +22% | +$3.88M | 0.01% | 720 |
|
|
2020
Q2 | $23.9M | Buy |
913,178
+244,175
| +36% | +$6.38M | 0.02% | 667 |
|
|
2020
Q1 | $11.9M | Sell |
669,003
-432
| -0.1% | -$7.71K | 0.01% | 852 |
|
|
2019
Q4 | $22.3M | Buy |
669,435
+29,974
| +5% | +$1M | 0.02% | 725 |
|
|
2019
Q3 | $15.2M | Buy |
639,461
+66,899
| +12% | +$1.59M | 0.01% | 813 |
|
|
2019
Q2 | $20.6M | Buy |
572,562
+56,953
| +11% | +$2.05M | 0.02% | 697 |
|
|
2019
Q1 | $19M | Buy |
515,609
+79,033
| +18% | +$2.92M | 0.02% | 693 |
|
|
2018
Q4 | $18.8M | Buy |
436,576
+16,748
| +4% | +$721K | 0.02% | 669 |
|
|
2018
Q3 | $19.8M | Buy |
419,828
+145,627
| +53% | +$6.88M | 0.02% | 739 |
|
|
2018
Q2 | $13.6M | Sell |
274,201
-77,799
| -22% | -$3.87M | 0.01% | 875 |
|
|
2018
Q1 | $17.5M | Buy |
352,000
+128,000
| +57% | +$6.36M | 0.02% | 793 |
|
|
2017
Q4 | $8.34M | Buy |
224,000
+124,000
| +124% | +$4.61M | 0.01% | 1144 |
|
|
2017
Q3 | $3.15M | Buy |
+100,000
| New | +$3.15M | ﹤0.01% | 1786 |
|